| abstract |
The invention relates to compounds of formula (I) or (II), which are of interest especially for inhibition of polymerization of amyloid β peptide, as model substances for synthesis of amyloid β peptide-ligands, as tools for the identification of other organic compounds with similar functional properties and/or as ligands for detection of amyloid deposits using e.g., positron emission tomography (PET). Formula (II) is: R 1 -A′-Y′-Leu-X′-Z′-B′-R 2 in which X′ means any group or amino acid imparting to the compound according to formula (I) the ability to bind to the KLVFF-sequence in amyloid β peptide, or two amino acids imparting the same ability, but with the proviso that one is not proline; Y′ means any amino acid; Z′ means any non-acidic amino acid; A′ means a direct bond or an α-amino acid bonded at the carboxyl terminal of the α-carboxy group or a di-, tri-, tetra- or pentapeptide bonded at the carboxyl terminal of the α-carboxy group; B′ means a direct bond or an α-amino acid bonded at the α-nitrogen or a di-, tri, tetra- or pentapeptide bonded at the α-nitrogen of the N-terminal α-amino acid; R 1 is H or —CO—R 3 bonded at the α-amino group of A′; R 2 is H, —OR 4 or NR 5 R 6 , all bonded to the α-carboxyl group of the α-carboxyterminal of B′; R 3 and R 4 are straight or branched carbon chain of 1-4 carbon atoms; R 5 and R 6 are independently H, alkyl, cycloalyl, aryl or substituted aryl or together are —(CH 2 ) n — where n is 4-5; and R 1 and R 2 together can form a hydrocarbon ring or heterocyclic ring; all α-amino acids being either D- or L-isomers. |